Font Size: a A A
Keyword [MPTP mouse model]
Result: 1 - 19 | Page: 1 of 1
1. Echinacoside Rescues Behavior Impairments And Deficits Of Nigrostriatal Dopaminergic Pathway In Subacute MPTP Mouse Model Of Parkinson's Disease
2. Changing Of DAT, 5-HT1A Receptor And 5-HTT In The MPTP Mouse Model Of Parkinson's Disease
3. Butylphthalide On The MPTP Mouse Model Of Parkinson's Disease Substantia Nigra Dopaminergic Neurons In TH, DAT, P-JNK/JNK Expression
4. Application Of Neural Stem Cell For Treatment Of Parkinson’s Disease In MPTP Mouse Model
5. Expression Of TLR4 And Its Effects On Release Of Inflammatory Mediators In Midbrain In A MPTP Mouse Model Of Parkinson’ Disease
6. Neuroprotective Effects Of Tetrahydroxystilbene Glucoside In The MPTP Mouse Model Of Parkinson’s Disease Through Activation Of PI3k/AKt Pathway
7. Neuroprotective Effects Of Salidroside In The MPTP Mouse Model Of Parkinson’s Disease Via The Inhibition Of ROS-NO Pathway
8. Clk1Participates In Neuroglial Activation And Neurotoxicity In MPTP Mouse Model Of Parkinson’s Disease
9. Protective Effect Of 6-Hydroxy-1H-indazole In MPTP Mouse Model Of Parkinson’s Disease
10. Neuroprotective Effects Of D-Ser~2-OXM In The MPTP Mouse Model Of Parkinson’s Disease
11. Research On Brain Iron Using Quantitative Susceptibility Mapping With Application To The MPTP Mouse Model Of Parkinson's Disease
12. Intestinal Pathology And Gut Microbiota In A MPTP Mouse Model Of Parkinson's Disease
13. The Mechanism And Neuroprotection Of Resveratrol Modulated AMPK-SIRT1 Pathway Deacetylated LC3 In MPTP Mouse Model Of Parkinson's Disease
14. Neuroprotective Effect And Mechanism Of Catalpol On MPTP Mouse Model Of Parkinson's Disease
15. TAT-tagging Exerts Positive Allosteric Modulation Of The PAC1-R And Enhances VIP Neuroprotective Effect In The MPTP Mouse Model Of Parkinson's Disease
16. CUMS-induced Depression Increased Susccptibility In An MPTP Mouse Model Of Parkinson's Disease Through P2X7R Mediated Inflammation
17. Comparative Study On The Inhibitory Effects Of GLP-1/GIP Dual Receptor Agonist DA-CH5 And GLP-1 Single Receptor Agonist NLY01 On NF-?B Inflammation Pathway In MPTP Mouse Model
18. Intragastric Administration Of Casein Leads To Nigrostriatal Disease Progressed Accompanied With Persistent Nigrostriatal-intestinal Inflammation Activited And Intestinal Microbiota-metabolic Disorders Induced In MPTP Mouse Model Of Parkinson's Disease
19. Neuroprotective Effect And Mechanism Of Melatonin On Mptp Mouse Model Of Parkinson's Disease
  <<First  <Prev  Next>  Last>>  Jump to